BridgeMD
New treatment option for Autism Spectrum Disorder
Official title Use of Immersive Virtual Reality to Train the Multisensory Processing Capacities of Children Aged 8 to 16 Years-old With an Autism Spectrum Disorder: Single-center Randomized Pilot Study in Parallel Groups - SEVIRE. (Sensory Virtual Reality)
ClinicalTrials.gov ID: NCT05171244
What this study is testing
- What it's testing
- Autism Spectrum Disorder (ASD) is defined as a neurodevelopmental disorder that affects the functioning and development of social communication (DSM5 - 2013). ASD causes particularities in sensory treatments (auditory, visual), qualified as uni-modal.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 16
You may be able to join if
- Child / adolescent aged 8 to 16 years, diagnosed with ASD (DSM-5, ADOS, ADI-R criteria).
- Without intellectual delay (QNV\> 70, WISC-IV or V, WAIS-III or IV).
- Benefiting from a treatment program at the University Center for Child Psychiatry (CHRU Bretonneau-Tours).
- Schooled in the ordinary school context (primary school, middle school, high school, ULIS).
- Having expressed their agreement to participate in the study.
You likely can't join if
- Neuromotor disorders.
- Uncorrected visual disorders.
- Hearing impairment.
- Known epilepsy.
- Anxiety syndromes identified.
- Hyper ADD / H type activity.
See the full eligibility criteria
- Child / adolescent aged 8 to 16 years, diagnosed with ASD (DSM-5, ADOS, ADI-R criteria).
- Without intellectual delay (QNV\> 70, WISC-IV or V, WAIS-III or IV).
- Benefiting from a treatment program at the University Center for Child Psychiatry (CHRU Bretonneau-Tours).
- Schooled in the ordinary school context (primary school, middle school, high school, ULIS).
- Having expressed their agreement to participate in the study.
- Whose parents or legal representatives have signed written consent.
- Whose parents or legal representatives are affiliated or beneficiaries of a social security scheme.
- Neuromotor disorders.
- Uncorrected visual disorders.
- Hearing impairment.
- Known epilepsy.
- Anxiety syndromes identified.
- Hyper ADD / H type activity.
- Treatment with methylphenidate. - Rare genetic syndrome.
The study team makes the final eligibility decision.
Where it's taking place
- Tours, Tours, France
- Tours, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tours, Tours, France; Tours, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.